Thomas Todoran to Risk Assessment
This is a "connection" page, showing publications Thomas Todoran has written about Risk Assessment.
Connection Strength
0.258
-
Comparison of 4 Acute Pulmonary Embolism Mortality Risk Scores in Patients Evaluated by Pulmonary Embolism Response Teams. JAMA Netw Open. 2020 08 03; 3(8):e2010779.
Score: 0.111
-
Catheter-based therapies for massive pulmonary embolism. Prog Cardiovasc Dis. 2010 Mar-Apr; 52(5):429-37.
Score: 0.054
-
Diagnosis and Treatment of Pulmonary Embolism During the Coronavirus Disease 2019 Pandemic: A Position Paper From the National PERT Consortium. Chest. 2020 12; 158(6):2590-2601.
Score: 0.028
-
Relation of Lymphangiogenic Factor Vascular Endothelial Growth Factor-D to Elevated Pulmonary Artery Wedge Pressure. Am J Cardiol. 2019 09 01; 124(5):756-762.
Score: 0.026
-
Rate of major adverse renal or cardiac events with iohexol compared to other low osmolar contrast media during interventional cardiovascular procedures. Catheter Cardiovasc Interv. 2019 02 01; 93(2):E90-E97.
Score: 0.025
-
Percutaneous revascularization of long femoral artery lesions for claudication: patency over 2.5 years and impact of systematic surveillance. Catheter Cardiovasc Interv. 2011 Jun 01; 77(7):1055-62.
Score: 0.015